期刊文献+

急性早幼粒细胞白血病完全缓解后出现真性红细胞增多症1例

A case of polycythemia vera after complete remission of acute promyelocytic leukemia
下载PDF
导出
摘要 本研究报道本院1例急性早幼粒细胞白血病(APL)完全缓解后出现真性红细胞增多症(PV)的病例,分析其临床资料及相关实验室检查,并作相关文献复习,从而探讨APL完全缓解后出现真性红细胞增多症的可能原因。该患者初诊时外院确诊为APL M3a型,经全反式维甲酸、亚砷酸及DA方案诱导及巩固治疗,并予维甲酸及甲氨蝶呤(MTX)维持治疗后,持续完全缓解,2020年于本院门诊血常规检查发现血红蛋白(Hb)持续异常升高,经一系列相关检查后确诊真性红细胞增多症。APL完全缓解后发生真性红细胞增多症可能与APL的治疗相关,也可能因患者新发基因突变导致,其相关性仍有待进一步讨论。 This paper reports 1 case of polycythemia vera(PV)after complete remission of acute promyelocytic leukemia(APL)in this hospital.The clinical data and related laboratory tests were analyzed,and the related literature was reviewed,so as to investigate the possible causes of true polycythemia vera after complete remission of APL.The patient was diagnosed with APL M3a type at the initial diagnosis.After induction and consolidation treatment with all trans retinoic acid,arsenic acid and DA regimen,and maintenance treatment with retinoic acid and methotrexate(MTX),the patient achieved complete remission.In 2020,hemoglobin(Hb)continued to be abnormally elevated in the outpatient blood routine examination of our hospital,and the diagnosis of polycythemia vera was confirmed after a series of relevant tests.The occurrence of polycythemia vera after complete remission in APL may be caused by the treatment of APL,or may be caused by new gene mutations.The truth remains to be further discussed.
作者 刘军伟 王卓 张洁 LIU Jun-wei;WANG Zhuo;ZHANG Jie(Department of Laboratory,Guangzhou Medical University Affiliated Hospital of Traditional Chinese Medicine,Guangzhou 510000,China)
出处 《中国现代药物应用》 2022年第15期170-172,共3页 Chinese Journal of Modern Drug Application
关键词 急性早幼粒细胞白血病 真性红细胞增多症 完全缓解 Acute promyelocytic leukemia Polycythemia vera Complete remission
  • 相关文献

参考文献6

二级参考文献20

  • 1傅元凤,于亚平,刘光陵.儿童急性早幼粒细胞白血病治疗后转型一例[J].中国全科医学,2006,9(16):1376-1377. 被引量:2
  • 2Leone G, Mele L, Pulsoni A, et al. The incidence of secondary leukemias. Haematologica,1999, 84:937-945.
  • 3Latagliata R,Petti MC, Fenu S, et al. Therapy-related myelodysplastic syndrome- acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Blood, 2002,99:822-824.
  • 4Lobe I, Rigal-Huguet F, Vekhoff A, et al. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. Leukemia,2003,17 : 1600-1604.
  • 5Batzios C, Hayes LA, He SZ, et al. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia. Am J Hematol,2009,84:715-719.
  • 6Metayer C, Curtis RE, Vose J, et al. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a muhicenter case-control study. Blood, 2003,101 : 4573- 4575.
  • 7Raimondi SC, Pui CH, Head DR, et al. Cytogenetically different leukemic clones at relapse of childhood acute lymphoblastic leukemia. Blood, 1993,82:576-580.
  • 8Au WY, Kumana CR, Lam CW, et al. Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemia. Leuk Res, 2007, 31: 105-108.
  • 9Litzow MR, Tarima S, Perez WS, et al. Allogenetic transplantantion for therapy-related myelodysplastie syndrome and acute myeloid leukemia. Blood, 2010, 115: 1850-1857.
  • 10程辉,余丹,周静,朱艳.58例继发性骨髓增生异常综合征临床分析[J].临床血液学杂志,2008,21(4):383-385. 被引量:6

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部